Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
5.76
+0.23 (4.16%)
Nov 22, 2024, 4:00 PM EST - Market closed

Kazia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Nov '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019 - 2015
Market Capitalization
257265812832
Upgrade
Market Cap Growth
-74.25%-74.25%-54.61%-54.40%298.54%98.02%
Upgrade
Enterprise Value
245244711328
Upgrade
Last Close Price
5.762.2911.6042.0098.6033.90
Upgrade
PS Ratio
4.094.0971609.368458.3611.2347.01
Upgrade
PB Ratio
-1.02-1.023.304.634.503.29
Upgrade
P/TBV Ratio
----10.7627.08
Upgrade
EV/Sales Ratio
14.672.7864547.016855.419.9240.38
Upgrade
Debt / Equity Ratio
-0.06-0.060.150.10--
Upgrade
Asset Turnover
0.100.100.000.000.370.04
Upgrade
Quick Ratio
0.220.220.711.103.321.97
Upgrade
Current Ratio
0.240.241.421.403.532.10
Upgrade
Return on Equity (ROE)
-2633.62%-2633.62%-134.97%-89.14%-32.41%-88.05%
Upgrade
Return on Assets (ROA)
-71.60%-71.60%-47.18%-33.76%-9.82%-34.45%
Upgrade
Return on Capital (ROIC)
-796.64%-796.64%-88.87%-54.74%-15.34%-53.82%
Upgrade
Earnings Yield
-71.22%-262.32%-51.49%-29.57%-4.94%-26.84%
Upgrade
FCF Yield
-24.84%-93.86%-38.14%-26.91%-5.34%-18.97%
Upgrade
Buyback Yield / Dilution
--39.12%-12.57%-61.08%-27.04%
Upgrade
Total Shareholder Return
--39.12%-12.57%-61.08%-27.04%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.